Thalidomide‐induced teratogenesis: History and mechanisms-Reference-Cited by-同舟云学术

Thalidomide‐induced teratogenesis: History and mechanisms

Published:2015-06 Issue:2 Volume:105 Page:140-156
ISSN:1542-975X
Container-title:Birth Defects Research Part C: Embryo Today: Reviews
language:en
Short-container-title:Birth Defect Res C

Author:

Vargesson Neil¹

Affiliation:

1. School of Medical SciencesInstitute of Medical Sciences, University of AberdeenForesterhill Aberdeen United Kingdom

Funder

Wellcome Trust

Publisher

Wiley

Subject

Developmental Biology,Embryology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdrc.21096

Reference119 articles.

1. Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidence for Prostaglandin H Synthase‐catalyzed bioactivation of thalidomide to a teratogenic reactive intermediate;Arlen RR;J Pharm and Exp Thera (JPET),1996

2. Thalidomide is not a human mutagen

3. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints

4. A case of Roberts syndrome described in 1737

5. TERATOGENIC EFFECTS OF THALIDOMIDE AND RELATED SUBSTANCES

Cited by 610 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India;Current Drug Safety;2024-05

2. The impact of ageing on the health and wellbeing of people with thalidomide embryopathy: a comparison of the health impact with the general population;Disability and Rehabilitation;2024-02-06

3. The Same but Not the Same: The Case of (S)-Naproxen/cis-1-Amino-2-indanol Chiral Resolution via Diastereomeric Salt Formation;Crystal Growth & Design;2024-02-05

4. Investigating the applicability domain of the hiPSC-based PluriLum assay: an embryotoxicity assessment of chemicals and drugs;Archives of Toxicology;2024-02-04

5. Why study human embryo development?;Developmental Biology;2024-02